Skip to content

Prevalence of anxiety and depression in post-treatment patients with ovarian cancer

Prevalence of anxiety and depression in post-treatment patients with ovarian cancer

Status
Unknown
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20231012007
Enrollment
127
Registered
2023-10-12
Start date
2023-08-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

in ovarian cancer pateint ovarian cancer depression anxiety

Interventions

Patients with ovarian cancer who have been initially diagnosed and have completed chemotherapy treatment within the first 3 years.
Screening
study group

Sponsors

Research fund of the faculty of medicine, Thammasat university
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Women who are over 20 years old and have been diagnosed with ovarian cancer at stages 1-4, have undergone surgery and/or chemotherapy, and are in the first 3 years of post-treatment follow-up at the Thammasat Hospital Oncology Clinic. 2. Women who can communicate, read, and understand the Thai language.

Exclusion criteria

Exclusion criteria: 1. Women who have been diagnosed with recurrent ovarian cancer. 2. Patients who refuse to participate in the research. 3. Women who have previously been diagnosed with anxiety and/or depression before being diagnosed with ovarian cancer. 4. Women who have previously been diagnosed with other types of cancer.

Design outcomes

Primary

MeasureTime frame
depression 3 years THAI HADS score,anxiety 3 years THAI HADS score

Secondary

MeasureTime frame
demographic data 3years age, status

Countries

Thailand

Contacts

Public Contactariya aoranaphakhaporn

Faculty of medicine, Thammasat university

pleum384@hotmail.com0944644145

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026